{
"info": {
"nct_id": "NCT01762280",
"official_title": "A Phase I Study of Famitinib Malate in Patients With Solid Tumor",
"inclusion_criteria": "* Histological confirmed advanced or metastatic solid tumor,at least one measurable lesion, larger than 10 mm in diameter by spiral CT scan(scanning layer ≤ 5 mm )\n* no standard therapy protocol available according to patients'condition\n* both sex, age 18 to 65\n* ECOG 0-1\n* Life expectancy more than 3 months\n* ALT,AST,TB≤1.5(UNL),normal serum creatinine level, normal electrolyte or can be corrected by medication\n* Subjects receiving damage caused by other therapeutic has been restored, the interval more than six weeks since the last receiving nitroso or mitomycin; more than 4 weeks since last receiving radiotherapy, other cytotoxic drugs or surgery\n* Understand and agree to sign informed consent form.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
"exclusion_criteria": "* Peripheral neuropathy ≥ Grade 2(according to NCI-CTC 3.0)\n* Preexisting uncontrolled hypertension defined as more than 140/90 mmHg by using single agent therapy, >Grade 1 (NCI-CTCAE 3.0 ) myocardial ischemia, arrhythmia,cardiac function insufficiency\n* PT, APTT, TT, Fbg abnormal(PT>16s,APTT>43s,TT>21s,Fbg<2g/L), or have hemorrhagic tendency or receiving the therapy of thrombolysis or anticoagulation\n* Active peptic ulcer\n* Previously medication include sunitinib\n* More than 4 weeks since the last clinical trial\n* Pregnant or lactating women\n* Women of childbearing age do not take effective contraceptive measures\n* Allergies, or known allergy history to components of the drug",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histological confirmed advanced or metastatic solid tumor,at least one measurable lesion, larger than 10 mm in diameter by spiral CT scan(scanning layer ≤ 5 mm )",
"criterions": [
{
"exact_snippets": "Histological confirmed advanced or metastatic solid tumor",
"criterion": "solid tumor",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "histological"
},
{
"requirement_type": "stage",
"expected_value": [
"advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "at least one measurable lesion, larger than 10 mm in diameter by spiral CT scan",
"criterion": "measurable lesion",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "lesion"
}
},
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "mm"
}
}
]
},
{
"exact_snippets": "spiral CT scan(scanning layer ≤ 5 mm )",
"criterion": "spiral CT scan",
"requirements": [
{
"requirement_type": "scanning layer",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "mm"
}
}
]
}
]
},
{
"line": "* no standard therapy protocol available according to patients'condition",
"criterions": [
{
"exact_snippets": "no standard therapy protocol available according to patients'condition",
"criterion": "standard therapy protocol",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* both sex, age 18 to 65",
"criterions": [
{
"exact_snippets": "both sex",
"criterion": "sex",
"requirements": [
{
"requirement_type": "allowed",
"expected_value": [
"male",
"female"
]
}
]
},
{
"exact_snippets": "age 18 to 65",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 65,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* ECOG 0-1",
"criterions": [
{
"exact_snippets": "ECOG 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Life expectancy more than 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy more than 3 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* ALT,AST,TB≤1.5(UNL),normal serum creatinine level, normal electrolyte or can be corrected by medication",
"criterions": [
{
"exact_snippets": "ALT,AST,TB≤1.5(UNL)",
"criterion": "ALT, AST, TB levels",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 1.5,
"unit": "UNL"
}
]
}
}
]
},
{
"exact_snippets": "normal serum creatinine level",
"criterion": "serum creatinine level",
"requirements": [
{
"requirement_type": "level",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "normal electrolyte or can be corrected by medication",
"criterion": "electrolyte levels",
"requirements": [
{
"requirement_type": "level",
"expected_value": "normal"
},
{
"requirement_type": "correction",
"expected_value": "can be corrected by medication"
}
]
}
]
},
{
"line": "* Subjects receiving damage caused by other therapeutic has been restored, the interval more than six weeks since the last receiving nitroso or mitomycin; more than 4 weeks since last receiving radiotherapy, other cytotoxic drugs or surgery",
"criterions": [
{
"exact_snippets": "damage caused by other therapeutic has been restored",
"criterion": "damage restoration",
"requirements": [
{
"requirement_type": "status",
"expected_value": "restored"
}
]
},
{
"exact_snippets": "the interval more than six weeks since the last receiving nitroso or mitomycin",
"criterion": "interval since last nitroso or mitomycin",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "more than 4 weeks since last receiving radiotherapy",
"criterion": "interval since last radiotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "more than 4 weeks since last receiving ... other cytotoxic drugs",
"criterion": "interval since last cytotoxic drugs",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "more than 4 weeks since last receiving ... surgery",
"criterion": "interval since last surgery",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Understand and agree to sign informed consent form.",
"criterions": [
{
"exact_snippets": "Understand and agree to sign informed consent form.",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "understanding",
"expected_value": true
},
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 65 Years",
"criterions": [
{
"exact_snippets": "maximum age of 65 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 65,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Peripheral neuropathy ≥ Grade 2(according to NCI-CTC 3.0)",
"criterions": [
{
"exact_snippets": "Peripheral neuropathy ≥ Grade 2",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "Grade"
}
}
]
}
]
},
{
"line": "* Preexisting uncontrolled hypertension defined as more than 140/90 mmHg by using single agent therapy, >Grade 1 (NCI-CTCAE 3.0 ) myocardial ischemia, arrhythmia,cardiac function insufficiency",
"criterions": [
{
"exact_snippets": "Preexisting uncontrolled hypertension defined as more than 140/90 mmHg",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 140,
"unit": "mmHg"
}
},
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 90,
"unit": "mmHg"
}
}
]
},
{
"exact_snippets": ">Grade 1 (NCI-CTCAE 3.0 ) myocardial ischemia",
"criterion": "myocardial ischemia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "Grade (NCI-CTCAE 3.0)"
}
}
]
},
{
"exact_snippets": ">Grade 1 (NCI-CTCAE 3.0 ) ... arrhythmia",
"criterion": "arrhythmia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "Grade (NCI-CTCAE 3.0)"
}
}
]
},
{
"exact_snippets": ">Grade 1 (NCI-CTCAE 3.0 ) ... cardiac function insufficiency",
"criterion": "cardiac function insufficiency",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "Grade (NCI-CTCAE 3.0)"
}
}
]
}
]
},
{
"line": "* PT, APTT, TT, Fbg abnormal(PT>16s,APTT>43s,TT>21s,Fbg<2g/L), or have hemorrhagic tendency or receiving the therapy of thrombolysis or anticoagulation",
"criterions": [
{
"exact_snippets": "PT>16s",
"criterion": "prothrombin time (PT)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 16,
"unit": "s"
}
}
]
},
{
"exact_snippets": "APTT>43s",
"criterion": "activated partial thromboplastin time (APTT)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 43,
"unit": "s"
}
}
]
},
{
"exact_snippets": "TT>21s",
"criterion": "thrombin time (TT)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 21,
"unit": "s"
}
}
]
},
{
"exact_snippets": "Fbg<2g/L",
"criterion": "fibrinogen (Fbg)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "g/L"
}
}
]
},
{
"exact_snippets": "hemorrhagic tendency",
"criterion": "hemorrhagic tendency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "receiving the therapy of thrombolysis",
"criterion": "thrombolysis therapy",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": true
}
]
},
{
"exact_snippets": "receiving the therapy of ... anticoagulation",
"criterion": "anticoagulation therapy",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": true
}
]
}
]
},
{
"line": "* Active peptic ulcer",
"criterions": [
{
"exact_snippets": "Active peptic ulcer",
"criterion": "peptic ulcer",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
}
]
},
{
"line": "* Previously medication include sunitinib",
"criterions": [
{
"exact_snippets": "Previously medication include sunitinib",
"criterion": "previous medication",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": [
"sunitinib"
]
}
]
}
]
},
{
"line": "* More than 4 weeks since the last clinical trial",
"criterions": [
{
"exact_snippets": "More than 4 weeks since the last clinical trial",
"criterion": "time since last clinical trial",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Pregnant or lactating women",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Women of childbearing age do not take effective contraceptive measures",
"criterions": [
{
"exact_snippets": "Women of childbearing age",
"criterion": "gender and reproductive status",
"requirements": [
{
"requirement_type": "gender",
"expected_value": "female"
},
{
"requirement_type": "reproductive status",
"expected_value": "childbearing age"
}
]
},
{
"exact_snippets": "do not take effective contraceptive measures",
"criterion": "contraceptive measures",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
}
]
},
{
"line": "* Allergies, or known allergy history to components of the drug",
"criterions": [
{
"exact_snippets": "Allergies, or known allergy history to components of the drug",
"criterion": "allergy history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Allergies, or known allergy history to components of the drug",
"criterion": "allergy to components of the drug",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}